New research on the composition and structure of a needle-like protein on the surface of bacteria may help scientists develop new strategies to thwart infection.

Scientists believe they have found a preventative therapy for Type 1 diabetes, by making the body's killer immune cells tolerate the insulin-producing cells they would normally attack and destroy.

Researchers have developed a new non-viral approach to gene therapy that they say will overcome side-effects associated with the current viral vectors - such as inflammation or the development of cancer.

For the first time, chemists have synthesized a complex compound - first discovered in ocean-living fungus - that has shown the ability to kill cancer cells.

An expert is calling on the Government to provide substantial new investment into the production of medical isotopes or face a dangerous shortage that threatens to compromise patient healthcare.

The largest-ever independent, laboratory-based evaluation of rapid diagnostic tests (RDTs) for malaria has shown that not all tests perform equally where they are needed most - in tropical environments.

A multi-disciplinary team of scientists are paving the way for the development of a powerful new strategy for both the early diagnosis and treatment of prostate cancer.

Nanotechnology is being used by academics to develop low-cost, disposable blood-testing kits that can be made available in GPs' surgeries.

UK Researchers have launched a simple online survey that will help scientists understand the speed with which killer diseases such as the swine flu outbreak could spread through the British population.

Ultraviolet lights could reduce the spread of tuberculosis in hospital wards and waiting rooms by 70%, according to a new study.

Researchers from Nottingham's two universities are joining forces to develop a simple blood test to diagnose Alzheimer's disease.

A Swedish physician has been awarded for developing a 3-D imaging technique ideal for post-mortem imaging and providing invaluable information for forensic investigation.

Immediate and accurate tests to diagnose and monitor bleeding and blood clotting disorders could soon be available at every GP's surgery.

Scientists have developed a new class of disposable, microplate-based optical biosensor capable of detecting protein-DNA interactions.

Scientists at UK fertility clinic CARE can now screen for chromosomal abnormalities in an ovum before it is fertilised under IVF - could this be the breakthrough that advances the field and bypasses ethical concerns?

The provision of pathology services in the NHS is increasingly dependent on Managed Laboratory Services (MLS) as more and more Trusts adopt this solution for their diagnostic requirements. The leading provider of innovative MLS to Pathology Departments in the UK, Roche, has witnessed this growing trend, which accounted for around 90% of their new centralised diagnostics business.

Increasing workloads has led to the NHS and commercial companies having a very close working relationship. Here we look at two areas that have seen the greatest change in the last decade, IT and biomarkers

Point of care meters are widely used for measuring glucose in hospitalised patients. Here we ask, just how reliable are the results of current hospital glucose meters?

The NHS currently spends around £9 billion a year on everything from paperclips to diagnostics of which pathology contributes significantly. The procurement process however can be a potential minefield for the unwary laboratory manager as biomedical scientist Barry Hill explains

Tele-pathology has promised lots and delivered very little over the last few years. Historically, people have cited technical boundaries and some do not like the idea of remote diagnosis, but a multi-disciplinary team in the UK has seen through these concerns

The demands on today's pathology service are driving many Trusts to assess current practices and explore new approaches to ensure enhanced service provision into the future. Here we take a look at how one Trust has gone about achieving its aim of providing an effective and efficient diagnostic service with improvements to clinical users and enhanced care for patients.

The in vitro diagnostics (IVD's) sold in this country fall into a range of areas which include clinical use by the NHS, consumer tests, research and forensic testing. The procurement landscape for most of these is quite straightforward but becomes more complex as the NHS procurement system comes into play.

With the clock ticking for all manufacturers of medical devices, the adoption of a single European standard appears to be a significant step towards promoting safer diagnostic testing and cost-effective healthcare.

The importance of understanding and acting on the results of laboratory investigations is vital to ensure patients receive the correct treatment and care, but are our new intake of junior doctors up to the task? MedLabNews investigates why it appears to be...TESTING TIMES FOR JUNIOR DOCTORS